Decheng Capital
North America, California, United States, Menlo Park
Description
Decheng Capital is a venture capital firm that provides capital to early and growth stage life science companies.
Investor Profile
Decheng Capital has made 59 investments, with 4 in the past 12 months and 27% as lead.
Stage Focus
- Series B (32%)
- Series C (31%)
- Series A (17%)
- Post Ipo Equity (5%)
- Series D (5%)
- Series E (3%)
- Series F (3%)
- Series Unknown (2%)
- Private Equity (2%)
Country Focus
- United States (92%)
- China (7%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Pharmaceutical
- Health Diagnostics
- Therapeutics
- Biopharma
- Life Science
- Medical Device
- Oncology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='translate(288.889 -214.211)'/%3e%3cuse xlink:href='%23a' transform='translate(108 342.749)'/%3e%3cuse xlink:href='%23a' transform='translate(469.189 342.749)'/%3e%3c/svg%3e)
'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
